Skip to main content
Equibles
NAMS logo

NAMS · NewAmsterdam Pharma Co N.V.

Track NAMS — free

Use NAMS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.90 -0.89 (-3.32%) At close · Aug 28
Rebalance outlook locked
Market Cap
$3.10B
Shares
119.54M

NewAmsterdam Pharma Co N.V. Earnings Call Transcripts

Quarterly earnings calls for NewAmsterdam Pharma Co N.V. (NAMS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-05
NewAmsterdam Pharma Co N.V. (NAMS) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
NewAmsterdam Pharma Co N.V. (NAMS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
NewAmsterdam Pharma Co N.V. (NAMS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
NewAmsterdam Pharma Co N.V. (NAMS) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-11
NewAmsterdam Pharma Co N.V. (NAMS) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
NewAmsterdam Pharma Co N.V. (NAMS) Q3 2025 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
NewAmsterdam Pharma Co N.V. (NAMS) Q2 2025 Earnings Call Transcript
Confident tone PREVAIL Trial Design and Interim Analysis Broadway Trial as Predictor Alzheimer's / Phase 2B Program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
NewAmsterdam Pharma Co N.V. (NAMS) Q1 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
NewAmsterdam Pharma Co N.V. (NAMS) Q4 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
NewAmsterdam Pharma Co N.V. (NAMS) Q3 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
NewAmsterdam Pharma Co N.V. (NAMS) Q2 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
NewAmsterdam Pharma Co N.V. (NAMS) Q1 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
NewAmsterdam Pharma Co N.V. (NAMS) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–13 of 13 earnings calls
Key facts CIK 1936258 CUSIP N62509109 13F (30d) 172 filings 170 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)